Intralipid: Difference between revisions

(Text replacement - "Category:Tox" to "Category:Toxicology")
(Text replacement - "2/2" to "secondary to")
Line 4: Line 4:
*Routes of Administration: IV
*Routes of Administration: IV
*Common Trade Names: Intralipid
*Common Trade Names: Intralipid
*Emergency department indications: [[Local anesthetic systemic toxicity]], refractory hemodynamic instability 2/2 ingestion of cardiodepressive medications / toxins  (i.e. [[Beta blocker]] or [[Calcium Channel Blocker]])
*Emergency department indications: [[Local anesthetic systemic toxicity]], refractory hemodynamic instability secondary to ingestion of cardiodepressive medications / toxins  (i.e. [[Beta blocker]] or [[Calcium Channel Blocker]])


==Adult Dosing==
==Adult Dosing==

Revision as of 06:27, 6 July 2016

General

Adult Dosing

  • 1.5 ml/kg bolus[1]
    • Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.[2]

Pediatric Dosing

Special Populations

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Asystole (case reported) [3]

Common

  • Pancreatitis[4]
  • Hypertriglyceridemia[4]

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:


Comments

See Also

External Links

References

  1. Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824
  2. Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.
  3. Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310
  4. 4.0 4.1 Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436